Showing results (161-170 of 294) with videos related to
Sort By:
Pageof 30
Journal of Clinical Psychopharmacology|April 1, 1983
Pharmacokinetic properties of benzodiazepine hypnoticsD J Greenblatt, D R Abernethy, M Divoll, et al.Clinical Pharmacokinetics|May 1, 1983
Clinical pharmacokinetics of the newer benzodiazepinesD J Greenblatt, M Divoll, D R Abernethy, et al.Pharmacology, Biochemistry, and Behavior|June 1, 1988
Low-dose alprazolam augments motor activity in miceF Lopez, L G Miller, D J Greenblatt, et al.The Journal of Pharmacology and Experimental Therapeutics|July 1, 1990
Chronic benzodiazepine administration. VI. A partial agonist produces behavioral effects without tolerance or receptor alterationsL G Miller, W R Galpern, D J Greenblatt, et al.Clinical Pharmacokinetics|January 1, 1995
Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacologyL L von Moltke, D J Greenblatt, J Schmider, et al.Biopharmaceutics & Drug Disposition|April 1, 1997
Metabolism of dextromethorphan in vitro: involvement of cytochromes P450 2D6 and 3A3/4, with a possible role of 2E1J Schmider, D J Greenblatt, S M Fogelman, et al.Drug Metabolism Reviews|May 21, 1999
Extrapolating in vitro data on drug metabolism to in vivo pharmacokinetics: evaluation of the pharmacokinetic interaction between amitriptyline and fluoxetineJ Schmider, L L von Moltke, R I Shader, et al.Journal of Clinical Pharmacology|November 1, 1979
Overdosage with pentobarbital and secobarbital: assessment of factors related to outcomeD J Greenblatt, M D Allen, J S Harmatz, et al.Journal of Clinical Pharmacology|May 1, 1990
The neuropsychiatric effects of aspartame in normal volunteersK A Lapierre, D J Greenblatt, J E Goddard, et al.Psychopharmacology|January 1, 1988
Acute barbiturate administration increases benzodiazepine receptor binding in vivoL G Miller, S I Deutsch, D J Greenblatt, et al.Pageof 30